trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Body Weight D001835 333 associated lipids
Lung Neoplasms D008175 171 associated lipids
Adenocarcinoma D000230 166 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Inflammation D007249 119 associated lipids
Hypertension D006973 115 associated lipids
Glioma D005910 112 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Arany I et al. Epigenetic modifiers exert renal toxicity through induction of p66shc. 2011 Anticancer Res. pmid:21965735
Sasaki Y et al. p53 negatively regulates the hepatoma growth factor HDGF. 2011 Cancer Res. pmid:22006999
Aoyama K et al. Nuclear c-Abl-mediated tyrosine phosphorylation induces chromatin structural changes through histone modifications that include H4K16 hypoacetylation. 2011 Exp. Cell Res. pmid:22001646
Ohtani K et al. Epigenetic regulation of endothelial lineage committed genes in pro-angiogenic hematopoietic and endothelial progenitor cells. 2011 Circ. Res. pmid:21980126
Hagiwara H et al. Histone deacetylase inhibitor trichostatin A enhances myogenesis by coordinating muscle regulatory factors and myogenic repressors. 2011 Biochem. Biophys. Res. Commun. pmid:22019851
Jafari S et al. Epigenetic modification does not determine the time of POU5F1 transcription activation in cloned bovine embryos. 2011 J. Assist. Reprod. Genet. pmid:22020531
Tseng AS et al. HDAC activity is required during Xenopus tail regeneration. 2011 PLoS ONE pmid:22022609
Rajak H et al. 2,5-Disubstituted-1,3,4-oxadiazoles/thiadiazole as surface recognition moiety: design and synthesis of novel hydroxamic acid based histone deacetylase inhibitors. 2011 Bioorg. Med. Chem. Lett. pmid:21875796
He HM et al. [The effects of a histone deacetylase (HDAC) inhibitor on endotoxin-induced endothelial cell injury]. 2011 Zhongguo Wei Zhong Bing Ji Jiu Yi Xue pmid:22005560
Sanders YY et al. Epigenetic regulation of thy-1 by histone deacetylase inhibitor in rat lung fibroblasts. 2011 Am. J. Respir. Cell Mol. Biol. pmid:20724553
Wang JP et al. Trichostatin A inhibits TGF-β1 induced in vitro chondrogenesis of hMSCs through Sp1 suppression. 2011 Differentiation pmid:21074928
Oyer JA et al. Aberrantly silenced promoters retain a persistent memory of the silenced state after long-term reactivation. 2011 Mutat. Res. pmid:21035468
Pabba C et al. Design and synthesis of aryl ether and sulfone hydroxamic acids as potent histone deacetylase (HDAC) inhibitors. 2011 Bioorg. Med. Chem. Lett. pmid:21109435
Vrzal R et al. Valproic acid augments vitamin D receptor-mediated induction of CYP24 by vitamin D3: a possible cause of valproic acid-induced osteomalacia? 2011 Toxicol. Lett. pmid:21115105
Coleman SL et al. Unsaturated fatty acids repress the expression of adipocyte fatty acid binding protein via the modulation of histone deacetylation in RAW 264.7 macrophages. 2011 Eur J Nutr pmid:21046125
Zhou S et al. Repression of P66Shc expression by SIRT1 contributes to the prevention of hyperglycemia-induced endothelial dysfunction. 2011 Circ. Res. pmid:21778425
Chik CL et al. Histone modifications on the adrenergic induction of type II deiodinase in rat pinealocytes. 2011 Mol. Cell. Endocrinol. pmid:21704117
Zhang L et al. ABA treatment of germinating maize seeds induces VP1 gene expression and selective promoter-associated histone acetylation. 2011 Physiol Plant pmid:21679193
Lin S et al. HIV-1 reactivation induced by apicidin involves histone modification in latently infected cells. 2011 Curr. HIV Res. pmid:21631428
Jugová A et al. Effects of epigenetic-based anti-cancer drugs in leukaemia and multiple myeloma cells. 2011 Cell Biol. Int. pmid:21635225
Wong CY et al. Epigenetic regulation of phosphatidylinositol 3,4,5-triphosphate-dependent Rac exchanger 1 gene expression in prostate cancer cells. 2011 J. Biol. Chem. pmid:21636851
Hayashi-Takanaka Y et al. Tracking epigenetic histone modifications in single cells using Fab-based live endogenous modification labeling. 2011 Nucleic Acids Res. pmid:21576221
Bouquet F et al. A DNA-dependent stress response involving DNA-PK occurs in hypoxic cells and contributes to cellular adaptation to hypoxia. 2011 J. Cell. Sci. pmid:21576354
Hawk JD et al. Post-training intrahippocampal inhibition of class I histone deacetylases enhances long-term object-location memory. 2011 Learn. Mem. pmid:21576516
Dong X et al. Histone deacetylase inhibitors upregulate Rap1GAP and inhibit Rap activity in thyroid tumor cells. 2011 Endocr. Relat. Cancer pmid:21367844
Zhu QY et al. C6-ceramide synergistically potentiates the anti-tumor effects of histone deacetylase inhibitors via AKT dephosphorylation and α-tubulin hyperacetylation both in vitro and in vivo. 2011 Cell Death Dis pmid:21368888
Hsu YF et al. p53 in trichostatin A induced C6 glioma cell death. 2011 Biochim. Biophys. Acta pmid:21376104
Ryhänen T et al. Influence of Hsp90 and HDAC inhibition and tubulin acetylation on perinuclear protein aggregation in human retinal pigment epithelial cells. 2011 J. Biomed. Biotechnol. pmid:20981255
Briggs B et al. Photosensitization by iodinated DNA minor groove binding ligands: Evaluation of DNA double-strand break induction and repair. 2011 J. Photochem. Photobiol. B, Biol. pmid:21440453
Seitz V et al. Classical Hodgkin's lymphoma shows epigenetic features of abortive plasma cell differentiation. 2011 Haematologica pmid:21393330
Agudelo M et al. Effects of alcohol on histone deacetylase 2 (HDAC2) and the neuroprotective role of trichostatin A (TSA). 2011 Alcohol. Clin. Exp. Res. pmid:21447001
Zhang Y et al. ERK1/2 activation plays important roles in the opposite effects of Trichostatin A in non-cancer and cancer cells. 2011 Toxicon pmid:21419152
Xiao J et al. Discovery, synthesis, and biological evaluation of novel SMN protein modulators. 2011 J. Med. Chem. pmid:21819082
Yang J et al. [Study of RASSF1A expression and promoter demethylation in Hep-2 cell line]. 2011 Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi pmid:21473137
Cui XS et al. Trichostatin A modulates apoptotic-related gene expression and improves embryo viability in cloned bovine embryos. 2011 Cell Reprogram pmid:21473694
Chen X et al. Design, synthesis and biological evaluation of hydroxamic acid derivatives as potential high density lipoprotein (HDL) receptor CLA-1 up-regulating agents. 2011 Molecules pmid:22048700
Sun JY et al. Histone deacetylase inhibitors demonstrate significant preclinical activity as single agents, and in combination with bortezomib in Waldenström's macroglobulinemia. 2011 Clin Lymphoma Myeloma Leuk pmid:21454220
Kong QR et al. [TSA improve transgenic porcine cloned embryo development and transgene expression]. 2011 Yi Chuan pmid:22049689
Min XJ et al. Dysfunction of volume-sensitive chloride channels contributes to cisplatin resistance in human lung adenocarcinoma cells. 2011 Exp. Biol. Med. (Maywood) pmid:21454376
Belakavadi M et al. Thyroid hormone suppression of β-amyloid precursor protein gene expression in the brain involves multiple epigenetic regulatory events. 2011 Mol. Cell. Endocrinol. pmid:21458529
Dávalos-Salas M et al. Gain of DNA methylation is enhanced in the absence of CTCF at the human retinoblastoma gene promoter. 2011 BMC Cancer pmid:21663659
El-Serafi AT et al. Epigenetic modifiers influence lineage commitment of human bone marrow stromal cells: Differential effects of 5-aza-deoxycytidine and trichostatin A. 2011 Differentiation pmid:20970916
Zelko IN et al. Histone acetylation regulates the cell-specific and interferon-γ-inducible expression of extracellular superoxide dismutase in human pulmonary arteries. 2011 Am. J. Respir. Cell Mol. Biol. pmid:21493784
Zhang FQ et al. Cell-cycle-dependent variations in the FTIR spectroscopy of HeLa cells treated with trichostatin A. 2011 Guang Pu Xue Yu Guang Pu Fen Xi pmid:22007388
da Costa Prando E et al. Evidence of epigenetic regulation of the tumor suppressor gene cluster flanking RASSF1 in breast cancer cell lines. 2011 Epigenetics pmid:22139571
Nagamine MK et al. In vitro inhibitory effect of trichostatin A on canine grade 3 mast cell tumor. 2011 Vet. Res. Commun. pmid:21472452
Kretzner L et al. Combining histone deacetylase inhibitor vorinostat with aurora kinase inhibitors enhances lymphoma cell killing with repression of c-Myc, hTERT, and microRNA levels. 2011 Cancer Res. pmid:21502403
Maruoka H et al. Low-molecular-weight compounds having neurotrophic activity in cultured PC12 cells and neurons. 2011 J. Biochem. pmid:21908547
Poplineau M et al. Raman microspectroscopy detects epigenetic modifications in living Jurkat leukemic cells. 2011 Epigenomics pmid:22126296
Qiu GH et al. Recognition and suppression of transfected plasmids by protein ZNF511-PRAP1, a potential molecular barrier to transgene expression. 2011 Mol. Ther. pmid:21540836
Kong Q et al. Effect of trichostatin A and 5-Aza-2'-deoxycytidine on transgene reactivation and epigenetic modification in transgenic pig fibroblast cells. 2011 Mol. Cell. Biochem. pmid:21541675
Wang QS et al. [Silence mechanism of WT1 gene in leukemic cell line U937]. 2011 Zhongguo Shi Yan Xue Ye Xue Za Zhi pmid:22040952
Park JW et al. Microbial transformation of trichostatin A to 2,3-dihydrotrichostatin A. 2011 J. Nat. Prod. pmid:21504214
Matoba S et al. RNAi-mediated knockdown of Xist can rescue the impaired postimplantation development of cloned mouse embryos. 2011 Proc. Natl. Acad. Sci. U.S.A. pmid:22065773
Bolleyn J et al. Effect of Trichostatin A on miRNA expression in cultures of primary rat hepatocytes. 2011 Toxicol In Vitro pmid:21513791
Rajasingh J et al. Improvement of cardiac function in mouse myocardial infarction after transplantation of epigenetically-modified bone marrow progenitor cells. 2011 PLoS ONE pmid:21799893
Ramsey MR et al. Physical association of HDAC1 and HDAC2 with p63 mediates transcriptional repression and tumor maintenance in squamous cell carcinoma. 2011 Cancer Res. pmid:21527555
Klawitter M et al. Human MMP28 expression is unresponsive to inflammatory stimuli and does not correlate to the grade of intervertebral disc degeneration. 2011 J Negat Results Biomed pmid:21801383
Nishikata I et al. Sumoylation of MEL1S at lysine 568 and its interaction with CtBP facilitates its repressor activity and the blockade of G-CSF-induced myeloid differentiation. 2011 Oncogene pmid:21516122
Tong Y et al. PTTG1 attenuates drug-induced cellular senescence. 2011 PLoS ONE pmid:21858218
Crump NT et al. Dynamic acetylation of all lysine-4 trimethylated histone H3 is evolutionarily conserved and mediated by p300/CBP. 2011 Proc. Natl. Acad. Sci. U.S.A. pmid:21518915
Bui HT et al. Histone deacetylase inhibition improves activation of ribosomal RNA genes and embryonic nucleolar reprogramming in cloned mouse embryos. 2011 Biol. Reprod. pmid:21753193
Biermann J et al. Histone deacetylase inhibitors sodium butyrate and valproic acid delay spontaneous cell death in purified rat retinal ganglion cells. 2011 Mol. Vis. pmid:21311741
Fortson WS et al. Histone deacetylase inhibitors, valproic acid and trichostatin-A induce apoptosis and affect acetylation status of p53 in ERG-positive prostate cancer cells. 2011 Int. J. Oncol. pmid:21519790
Huang KT et al. Aberrant DNA methylation but not mutation of CITED4 is associated with alteration of HIF-regulated genes in breast cancer. 2011 Breast Cancer Res. Treat. pmid:21755341
Inoue H et al. Analysis of expression and structure of the rat GH-secretagogue/ghrelin receptor (Ghsr) gene: roles of epigenetic modifications in transcriptional regulation. 2011 Mol. Cell. Endocrinol. pmid:21756973
Watanabe Y and Tanaka M p62/SQSTM1 in autophagic clearance of a non-ubiquitylated substrate. 2011 J. Cell. Sci. pmid:21771882
Li S et al. Autotaxin is induced by TSA through HDAC3 and HDAC7 inhibition and antagonizes the TSA-induced cell apoptosis. 2011 Mol. Cancer pmid:21314984
Fu S et al. Involvement of histone acetylation of Sox17 and Foxa2 promoters during mouse definitive endoderm differentiation revealed by microRNA profiling. 2011 PLoS ONE pmid:22132182
Kumar A et al. γ-radiation induces cellular sensitivity and aberrant methylation in human tumor cell lines. 2011 Int. J. Radiat. Biol. pmid:21815748
Tan L et al. Trichostatin A restores Apaf-1 function in chemoresistant ovarian cancer cells. 2011 Cancer pmid:20925046
Jackson K et al. Epigenetic silencing of somatostatin in gastric cancer. 2011 Dig. Dis. Sci. pmid:20927589
Sahu GK and Cloyd MW Latent HIV in primary T lymphocytes is unresponsive to histone deacetylase inhibitors. 2011 Virol. J. pmid:21838863
Yu D et al. Clonal Rett Syndrome cell lines to test compounds for activation of wild-type MeCP2 expression. 2011 Bioorg. Med. Chem. Lett. pmid:21840716
Atanackovic D et al. Cancer-testis antigen expression and its epigenetic modulation in acute myeloid leukemia. 2011 Am. J. Hematol. pmid:21898529
Paterson S et al. Histone deacetylase inhibitors increase human arylamine N-acetyltransferase-1 expression in human tumor cells. 2011 Drug Metab. Dispos. pmid:20870783
Wang JP et al. Recapitulation of fibromatosis nodule by multipotential stem cells in immunodeficient mice. 2011 PLoS ONE pmid:21901157
Nakaya Y et al. Epigenetic regulation on the 5'-proximal CpG island of human porcine endogenous retrovirus subgroup A receptor 2/GPR172B. 2011 Microbes Infect. pmid:20951222
Robers MB et al. Measurement of the cellular deacetylase activity of SIRT1 on p53 via LanthaScreen® technology. 2011 Mol Biosyst pmid:20931131
Hsu YF et al. MAPK phosphatase-1 contributes to trichostatin A inhibition of cyclooxygenase-2 expression in human umbilical vascular endothelial cells exposed to lipopolysaccharide. 2011 Biochim. Biophys. Acta pmid:21911040
Crandall JE et al. Retinoic acid influences neuronal migration from the ganglionic eminence to the cerebral cortex. 2011 J. Neurochem. pmid:21895658
Bogaard HJ et al. Suppression of histone deacetylases worsens right ventricular dysfunction after pulmonary artery banding in rats. 2011 Am. J. Respir. Crit. Care Med. pmid:21297075
Jafarpour F et al. Somatic cell-induced hyperacetylation, but not hypomethylation, positively and reversibly affects the efficiency of in vitro cloned blastocyst production in cattle. 2011 Cell Reprogram pmid:21919704
Furumai R et al. Histone deacetylase inhibitors block nuclear factor-κB-dependent transcription by interfering with RNA polymerase II recruitment. 2011 Cancer Sci. pmid:21299717
Chen S et al. [Effect of trichostatin alone and combination with imatinb on the proliferation and apoptosis of the K562R cells]. 2011 Zhong Nan Da Xue Xue Bao Yi Xue Ban pmid:21937807
Chen WP et al. Trichostatin A inhibits expression of cathepsins in experimental osteoarthritis. 2011 Rheumatol. Int. pmid:20390279
Stoppani E et al. Point mutated caveolin-3 form (P104L) impairs myoblast differentiation via Akt and p38 signalling reduction, leading to an immature cell signature. 2011 Biochim. Biophys. Acta pmid:21182936
Puppin C et al. Histone deacetylase inhibitors control the transcription and alternative splicing of prohibitin in thyroid tumor cells. 2011 Oncol. Rep. pmid:21152868
Tsai PF et al. Interplay between PKCδ and Sp1 on histone deacetylase inhibitor-mediated Epstein-Barr virus reactivation. 2011 J. Virol. pmid:21159880
Nandakumar V et al. (-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells. 2011 Carcinogenesis pmid:21209038
Kang H and Roh S Extended exposure to trichostatin A after activation alters the expression of genes important for early development in nuclear transfer murine embryos. 2011 J. Vet. Med. Sci. pmid:21187677
Mitmaker EJ et al. Modulation of matrix metalloproteinase activity in human thyroid cancer cell lines using demethylating agents and histone deacetylase inhibitors. 2011 Surgery pmid:21193210
Liao M et al. Coactivator function of positive cofactor 4 (PC4) in Sp1-directed luteinizing hormone receptor (LHR) gene transcription. 2011 J. Biol. Chem. pmid:21193408
Erb TM et al. Paracrine and epigenetic control of trophectoderm differentiation from human embryonic stem cells: the role of bone morphogenic protein 4 and histone deacetylases. 2011 Stem Cells Dev. pmid:21204619
Farinas B and Mas P Functional implication of the MYB transcription factor RVE8/LCL5 in the circadian control of histone acetylation. 2011 Plant J. pmid:21205033
Host L et al. Cocaine self-administration alters the expression of chromatin-remodelling proteins; modulation by histone deacetylase inhibition. 2011 J. Psychopharmacol. (Oxford) pmid:19939859
Muralidhar SA et al. Histone deacetylase 9 activates gamma-globin gene expression in primary erythroid cells. 2011 J. Biol. Chem. pmid:21078662
Chakravarty G et al. Cytoplasmic compartmentalization of SOX9 abrogates the growth arrest response of breast cancer cells that can be rescued by trichostatin A treatment. 2011 Cancer Biol. Ther. pmid:21084857
Meng Y et al. Epigenetic inactivation of the SFRP1 gene in esophageal squamous cell carcinoma. 2011 Dig. Dis. Sci. pmid:21567192
Puppin C et al. Histone deacetylase inhibitors induce thymidine phosphorylase expression in cultured breast cancer cell lines. 2011 Oncol. Rep. pmid:21617864